$2.02
-0.04-1.94%
最終更新: Oct 23, 12:30 PM
Benzinga
Benzinga
Benzinga
金曜日, 10 23
Benzinga
© 2026 Benzinga | All Rights Reserved
Acumen Pharmaceuticals (ABOS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.40 | $-0.49 | $-0.53 | $-0.66 |
| Actual | $-0.45 | $-0.33 | $-0.41 | $-0.44 |
| Surprise | -12.5% | +32.6% | +22.6% | +33.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.40 | $-0.39 |
| Revenue | ||
| Consensus | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.45 | $-0.40 | -12.5 % |
| Q1 | May 12, 2026 | $-0.33 | $-0.49 | 32.6 % |
| Q4 | Mar 26, 2026 | $-0.41 | $-0.53 | 22.6 % |
| Q3 | Nov 12, 2025 | $-0.44 | $-0.66 | 33.3 % |